CBU Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CBU is a good buy right now for a beginner with a long-term focus and $50,000-$100,000 to invest. The stock shows a constructive uptrend, supportive analyst sentiment, and no negative news catalyst. While insider selling and a neutral hedge fund posture are mild drawbacks, the overall setup is favorable and the current price near resistance still looks acceptable for a long-term entry. I would rate it as a buy, not a wait-and-see name.
CBU's technical trend is bullish. The stock is trading above key moving averages with SMA_5 > SMA_20 > SMA_200, which signals a healthy uptrend. MACD histogram is positive and expanding at 0.276, confirming improving momentum. RSI_6 at 74.21 suggests the stock is somewhat extended in the short term, but not enough to negate the broader trend. Price at 67.73 is just above R1 at 67.153 and below R2 at 68.845, so the stock is testing resistance while remaining in an upward channel. Overall, the price structure supports continuation rather than breakdown.
Analyst sentiment is constructive, with Raymond James raising the price target to $75 and maintaining a Strong Buy rating. The firm highlighted broad-based business momentum, including strength in both banking operations and fee income, which makes up 37% of revenue. Piper Sandler also raised its target to $66 and noted potential upside in net interest income, loan growth, and expenses versus outlook. There has been no negative news in the last week, and the lack of recent bad headlines is supportive.
Insiders have been selling, and the selling amount increased 226.35% over the last month, which is the main cautionary signal. Hedge funds are neutral with no significant accumulation trend. The stock is also near short-term resistance, and the RSI is elevated, which may limit immediate upside. There is no recent news catalyst to provide a fresh breakout trigger.
No usable latest-quarter financial snapshot was provided due to a data error, so a direct quarter-by-quarter review is unavailable. Based on the analyst commentary, however, recent quarter trends appear positive, with mentions of strong business momentum, a PPNR beat, lower operating expenses, and stable to improving net interest income and loan growth. The latest referenced season is Q1, and the commentary suggests healthy operating performance rather than deterioration.
Analyst sentiment is positive overall. Raymond James upgraded its price target to $75 from $73 and kept a Strong Buy rating, which is the more important view in the current data set. Piper Sandler also lifted its target to $66 from $62 but kept a Neutral rating, showing some caution. The Wall Street pros view is net bullish: one major firm sees strong momentum and upside, while the more conservative view still acknowledges upside in fundamentals. The balance of opinion leans favorable.
